Cytospire Therapeutics

StartupBiotech & Life SciencesBritish

Biopharmaceutical company developing first-in-class pan-gamma delta T cell engagers for solid tumours; lead programme CYT-X300 targets EGFR-positive cancers.

Locations

London, United Kingdom (Headquarters)

London Innovation Centre, 20 Water Street, London, Greater London, E14 5GX, United Kingdom

View on map